BCL2A1 Antikörper (C-Term)
Kurzübersicht für BCL2A1 Antikörper (C-Term) (ABIN926948)
Target
Alle BCL2A1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Ratte (Rattus), Maus, Rind (Kuh), Hund, Schwein
-
Aufreinigung
- Purified
-
Immunogen
- BCL2 A1 antibody was raised in rabbit using the C terminal of BCL2 1 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
BCL2A1 Blocking Peptide, (ABIN938316), is also available for use as a blocking control in assays to test for specificity of this BCL2A1 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- BCL2A1 (BCL2-Related Protein A1 (BCL2A1))
-
Andere Bezeichnung
- BCL2A1
-
Hintergrund
- BCL2A1s a member of the BCL-2 protein family. The proteins of this family form hetero- or homodimers and act as anti- and pro-apoptotic regulators that are involved in a wide variety of cellular activities such as embryonic development, homeostasis and tumorigenesis. The protein encoded by this gene is able to reduce the release of pro-apoptotic cytochrome c from mitochondria and block caspase activation. Synonyms: Polyclonal BCL2A1 antibody, Anti-BCL2A1 antibody, BCL2-related protein A1 antibody.
Target
-